Insufficient scRNA-seq data for expression of PDCD1LG2 at single-cell level.
Insufficient scRNA-seq data for expression of PDCD1LG2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 468.86 | 577 / 578 | 86% | 8.54 | 990 / 1155 |
breast | 100% | 380.67 | 459 / 459 | 84% | 6.52 | 937 / 1118 |
uterus | 95% | 162.43 | 162 / 170 | 64% | 5.05 | 295 / 459 |
skin | 95% | 348.39 | 1711 / 1809 | 62% | 6.20 | 293 / 472 |
thymus | 96% | 130.85 | 630 / 653 | 58% | 4.21 | 352 / 605 |
esophagus | 84% | 107.72 | 1210 / 1445 | 61% | 4.11 | 112 / 183 |
kidney | 80% | 82.40 | 71 / 89 | 62% | 4.74 | 558 / 901 |
bladder | 86% | 124.90 | 18 / 21 | 52% | 5.13 | 263 / 504 |
intestine | 78% | 87.58 | 751 / 966 | 48% | 2.73 | 255 / 527 |
ovary | 69% | 83.74 | 125 / 180 | 55% | 2.92 | 238 / 430 |
stomach | 47% | 48.48 | 169 / 359 | 63% | 3.87 | 180 / 286 |
adipose | 100% | 400.21 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 634.64 | 241 / 241 | 0% | 0 | 0 / 0 |
prostate | 77% | 90.12 | 188 / 245 | 22% | 0.75 | 112 / 502 |
lymph node | 0% | 0 | 0 / 0 | 97% | 36.10 | 28 / 29 |
tonsil | 0% | 0 | 0 / 0 | 96% | 8.45 | 43 / 45 |
blood vessel | 92% | 158.98 | 1230 / 1335 | 0% | 0 | 0 / 0 |
heart | 89% | 135.42 | 768 / 861 | 0% | 0 | 0 / 0 |
adrenal gland | 62% | 51.55 | 160 / 258 | 17% | 0.63 | 39 / 230 |
muscle | 78% | 79.52 | 623 / 803 | 0% | 0 | 0 / 0 |
brain | 14% | 11.47 | 367 / 2642 | 55% | 4.69 | 390 / 705 |
pancreas | 4% | 2.69 | 14 / 328 | 63% | 3.70 | 113 / 178 |
liver | 40% | 33.50 | 91 / 226 | 20% | 1.37 | 81 / 406 |
peripheral blood | 27% | 179.77 | 247 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 21% | 1.21 | 17 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0071222 | Biological process | cellular response to lipopolysaccharide |
GO_0031295 | Biological process | T cell costimulation |
GO_0032689 | Biological process | negative regulation of type II interferon production |
GO_0006955 | Biological process | immune response |
GO_0002250 | Biological process | adaptive immune response |
GO_0042102 | Biological process | positive regulation of T cell proliferation |
GO_0046007 | Biological process | negative regulation of activated T cell proliferation |
GO_0042130 | Biological process | negative regulation of T cell proliferation |
GO_0032693 | Biological process | negative regulation of interleukin-10 production |
GO_0007166 | Biological process | cell surface receptor signaling pathway |
GO_0009897 | Cellular component | external side of plasma membrane |
GO_0005576 | Cellular component | extracellular region |
GO_0005886 | Cellular component | plasma membrane |
GO_0012505 | Cellular component | endomembrane system |
GO_0005515 | Molecular function | protein binding |
GO_0003674 | Molecular function | molecular_function |
Gene name | PDCD1LG2 |
Protein name | Programmed cell death 1 ligand 2 (PD-1 ligand 2) (PD-L2) (PDCD1 ligand 2) (Programmed death ligand 2) (Butyrophilin B7-DC) (B7-DC) (CD antigen CD273) |
Synonyms | B7DC PDCD1L2 PDL2 CD273 |
Description | FUNCTION: Involved in the costimulatory signal, essential for T-cell proliferation and IFNG production in a PDCD1-independent manner. Interaction with PDCD1 inhibits T-cell proliferation by blocking cell cycle progression and cytokine production (By similarity). . |
Accessions | Q9BQ51 ENST00000397747.5 [Q9BQ51-1] |